Schedule 13G ownership disclosure

ENGENE HOLDINGS INC

Common Shares, no par value per share · CUSIP: 29286M105

Event date: 2025-01-27

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • BIOTECHNOLOGY VALUE FUND L P

    Shares: 505,835.00 · Class: 1%

  • BVF I GP LLC

    Shares: 505,835.00 · Class: 1%

  • BIOTECHNOLOGY VALUE FUND II LP

    Shares: 383,352.00 · Class: 0.7%

  • BVF II GP LLC

    Shares: 383,352.00 · Class: 0.7%

  • Biotechnology Value Trading Fund OS LP

    Shares: 43,786.00 · Class: 0.1%

  • BVF Partners OS Ltd.

    Shares: 43,786.00 · Class: 0.1%

  • BVF GP HOLDINGS LLC

    Shares: 889,187.00 · Class: 1.7%

  • BVF PARTNERS L P/IL

    Shares: 945,402.00 · Class: 1.8%

  • BVF INC/IL

    Shares: 945,402.00 · Class: 1.8%

  • LAMPERT MARK N

    Shares: 945,402.00 · Class: 1.8%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000921895-25-000197
Form type
SCHEDULE 13G/A
Filer
BIOTECHNOLOGY VALUE FUND L P
CIK
CIK 918923
Filed
Jan 29, 2025
Reporting period
Jan 27, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub